Contrl group:Placebo

3 trials

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine

Conditions

Cancer-related fatigueDiabetic kidney disease

Phase 4

Zhengyuan Capsule in the treatment of chemotherapy-related cancer-related fatigue in patients with unresectable stage IIIB-IV non-small cell lung cancer--a multicenter, randomized, double-blind, parallel, placebo-controlled clinical trial

Active, not recruitingITMCTR2000004062

The First Affiliated Hospital of Guangzhou University of Chinese MedicineCancer-related fatigue

Start: 2020-11-23Updated: 2023-02-20

Zhengyuan Capsule in the treatment of chemotherapy-related cancer-related fatigue in patients with unresectable stage IIIB-IV non-small cell lung cancer--a multicenter, randomized, double-blind, parallel, placebo-controlled clinical trial

Active, not recruitingChiCTR2000040061

The First Affiliated Hospital of Guangzhou University of Chinese MedicineCancer-related fatigue

Start: 2020-11-23Updated: 2021-12-21

Unknown Phase

Optimization research on the comprehensive prevention and treatment scheme of diabetic nephropathy renal failure based on the shenluozhengjia theory.

Active, not recruitingChiCTR-IOR-17012681

Dongzhimen Hospital, Beijing University of Chinese MedicineDiabetic kidney disease

Start: 2017-10-01Updated: 2017-10-02

Related Papers

Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial

Journal of Thoracic Disease2022-11-014 citations